site stats

Nrbo shares outstanding

WebNEUROBO PHARMACEUTICALS INC - NRBO. Trading System Performance for NRBO. Appeared in Recent Stock Splits screen on 2024-10-11 2024-02-08: Short Sale … WebShares Outstanding and Shares Float provided by Capital IQ. Funds Disclosing Short Positions - US-Domiciled This section shows US-domiciled institutions, funds, and major …

NRBO Stock Price and Chart — NASDAQ:NRBO — TradingView

WebA company's revenues divided by shares outstanding. Compare it to its 3-year average and industry average. 0.00: 0.00: ... NRBO is overvalued when compared to its 3-year average PE Ratio. 2015 ... Web12 sep. 2024 · NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) ("NeuroBo" or the "Company"), a clinical-stage biotechnology company, announced today a 1-for-30 … flicker versus red headed woodpecker https://cleanbeautyhouse.com

Neurobo Pharmaceuticals Inc Share Price Today NASDAQ NRBO …

WebFind out all the key statistics for NeuroBo Pharmaceuticals, Inc. (NRBO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. WebIt’s calculated by multiplying the current market price by the total number of shares outstanding. Northwest Biotherapeutics Inc market cap is $635.14M. What is the 52-week high for Northwest Biotherapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or one year. Web15 mrt. 2024 · In depth view into NeuroBo Pharmaceuticals Percent of Shares Outstanding Short including historical data from 2016, charts and stats. NeuroBo Pharmaceuticals Inc … chem 1c ucsc

NeuroBo Pharma Announces 1-for-30 Reverse Split Of Common …

Category:Stock Summary - TD Ameritrade

Tags:Nrbo shares outstanding

Nrbo shares outstanding

Stock Summary - TD Ameritrade

Web12 apr. 2024 · NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) announced its earnings results on Monday, November, 15th. The company reported ($4.80) earnings per share … Web31 mrt. 2024 · Neurobo Pharmaceuticals, Inc. (NRBO) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024. Home. SEC Filings. Neurobo …

Nrbo shares outstanding

Did you know?

Web13 sep. 2024 · While NRBO currently has outstanding shares of around 26.7 million, this figure is expected to drop to just under 1 million shares upon initiation of the reverse … Web30 sep. 2024 · Common stock, $ 0.001 par value per share, 100,000,000 shares authorized as of September 30, 2024 and December 31, 2024; 888,693 shares issued and outstanding as of September 30, 2024 and December 31, 2024. 1 1 Additional paid–in capital 97,056 96,420 Accumulated other comprehensive income — 4 Accumulated deficit

WebNeuroBo Pharmaceuticals Inc (NRBO) stock price, GURU trades, performance, financial stability, ... Less Shares Outstanding yoy Higher Gross Margin yoy Higher Asset Turnover yoy NeuroBo Pharmaceuticals Inc Filings 10-K … WebNRBO: NeuroBo Pharmaceuticals balance sheet. Get the latest balance sheet from Zacks Investment Research.

Web7 apr. 2024 · See the latest NeuroBo Pharmaceuticals Inc stock price (NASDAQ:NRBO), related news, valuation, dividends and more to help you make your investing decisions. Web4 apr. 2024 · (NASDAQ: NRBO) Neurobo Pharmaceuticals currently has 27,176,685 outstanding shares. With Neurobo Pharmaceuticals stock trading at $0.72 per share, …

Web1 apr. 2024 · NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced financial results for the year ended ... 2024 …

Web13 apr. 2024 · NRBO NeuroBo Pharmaceuticals, Inc.Stock Price & Overview. $0.71 -0.02 ( -2.08%) 3:57 PM 04/06/23. NASDAQ $USD Post-Market: $0.73 +0.03 (+3.55%) 7:59 … chem 1clWeb5 aug. 2016 · Get the market cap charts for Neurobo Pharmaceuticals (NRBO). 100% free, no signups. Get 20 years of historical market cap charts for NRBO stock and other companies. ... It's determined by multiplying the current … flicker vs woodpeckerWeb2 dec. 2024 · Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 7.38% to $1.6 during Thursday's after-market session. The market value of their outstanding shares is at $42.5 million. chem1 itera life